Search - tctmd.com

Displaying 421 - 440 of 651

Presentation TCT 2018

Case #6: Closing the Wide-Mouthed Multilobed LAA

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #5: A Case of Image Fusion Technology to Guide LAA Exclusion

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #4: A Case Demonstrating Why I Prefer ICE Over TEE for LAA Occlusion

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #3: A Case Where Procedural Guidance With TEE Made all the Difference

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #2: A Difficult Transseptal Puncture for an LAA Occlusion Procedure

Presenter: Maurice Buchbinder, Vivek Y. Reddy, Habib Gamra, Aaron V. Kaplan, Ulf Landmesser, Petr Neuzil, Jai-Wun Park, Kolja Sievert

September 23, 2018

Presentation TCT 2018

Case #1: Acute LAA Closure Device Embolization With Challenging Retrieval

Presenter: Maurice Buchbinder, Vivek Y. Reddy

September 23, 2018

Presentation TCT 2018

Rationale for Combining TAVR and LAAC in AF Patients: An Introduction to the WATCH-TAVR Trial

Presenter: Susheel K. Kodali, Vinod H. Thourani, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

Featured Presentation: Simultaneous LAA Closure With Structural Heart Procedures - Indications and Postinterventional Management

Presenter: Bagrat Alekyan, Juan F. Granada, Samir R. Kapadia

September 22, 2018

Presentation TCT 2018

Considerations for LAA Closure Devices: FDA Perspective

Presenter: Andrew Farb

September 22, 2018

Presentation TCT 2018

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

Presenter: Akihide Konishi

September 22, 2018

Presentation TCT 2018

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

Presenter: Marek Grygier

September 22, 2018

Presentation TCT 2018

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Presenter: Shephal Doshi

September 22, 2018

News Conference News TCT 2018

Novel LAA Closure Device Shows Promise in Early Experience

L.A. McKeown

September 22, 2018

Manuscript

Unexpected Murmur after Percutaneous Left Atrial Appendage Occlusion

September 05, 2018

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Shelley Wood

July 20, 2018

Presentation The Structural Heart Disease Summit 2018

Early and Late PFO Closure Complications

Presenter: John D. Carroll, Brij Maini, Zahid Amin

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Basic and Advanced PFO Closure Techniques

Presenter: John D. Carroll, Brij Maini

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

The Spectrum of PFO Closure Devices: Similarities and Meaningful Differences

Presenter: John D. Carroll, Brij Maini

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Residual Leaks After LAA Closure: Surveillance, Diagnosis, and Treatment (With Cases)

Presenter: Robert J. Sommer, Brian K. Whisenant

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Pericardial Effusions and Tamponade After LAA Closure: Frequency, Mechanisms, and Treatment (With Cases)

Presenter: Robert J. Sommer, Brian K. Whisenant, Saibal Kar

June 23, 2018

Advertisement

Case #6: Closing the Wide-Mouthed Multilobed LAA

Case #5: A Case of Image Fusion Technology to Guide LAA Exclusion

Case #4: A Case Demonstrating Why I Prefer ICE Over TEE for LAA Occlusion

Case #3: A Case Where Procedural Guidance With TEE Made all the Difference

Case #2: A Difficult Transseptal Puncture for an LAA Occlusion Procedure

Case #1: Acute LAA Closure Device Embolization With Challenging Retrieval

Rationale for Combining TAVR and LAAC in AF Patients: An Introduction to the WATCH-TAVR Trial

Featured Presentation: Simultaneous LAA Closure With Structural Heart Procedures - Indications and Postinterventional Management

Considerations for LAA Closure Devices: FDA Perspective

Point to Consider in the Review of the LAAC Related Devices: Japanese Regulatory View: PMDA

The Current Target Population for LAAC Closure Based on the Results of Clinical Trials in Europe

The Overview of Clinical Trials and Current Target Population for LAAC Closure

Novel LAA Closure Device Shows Promise in Early Experience

Unexpected Murmur after Percutaneous Left Atrial Appendage Occlusion

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

Early and Late PFO Closure Complications

Basic and Advanced PFO Closure Techniques

The Spectrum of PFO Closure Devices: Similarities and Meaningful Differences

Residual Leaks After LAA Closure: Surveillance, Diagnosis, and Treatment (With Cases)

Pericardial Effusions and Tamponade After LAA Closure: Frequency, Mechanisms, and Treatment (With Cases)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content